Actavia Life Sciences Inc Asset Turnover Ratio (RASP), as of second quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Actavia Life Sciences Inc   (RASP)
 

Actavia Life Sciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Mar 31 2024, Actavia Life Sciences Inc has not recorded any assets.
Visit Actavia Life Sciences Inc Balance sheet

Within sector Actavia Life Sciences Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2024 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RASP Asset Turnover Ratio (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter		 (Jun 30 2023)
III. Quarter		 (Mar 31 2023)
II. Quarter
Y / Y Asset Change -9.68 % -56.79 % 12.17 % -48.43 % 46.5 %
Y / Y Revenue Change - -52.22 % -99.73 % - -22.01 %
Asset Turnover Ratio (TTM) - 0.16 0.14 - 1.81
RASP's Total Ranking # # # # #
Seq. Asset Change 80.46 % -72.64 % 158.11 % -29.14 % -13.67 %
Seq. Revenue Change - 282.24 % - - 821.5 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




RASP Company Profile • Back to RASP Efficiency Comparisons • Compare RASP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Proqr Therapeutics N v   0.03 $ 4.831  Millions$ 162.850  Millions
Oncternal Therapeutics Inc   0.03 $ 1.151  Millions$ 39.960  Millions
Generation Bio Co   0.03 $ 9.963  Millions$ 361.753  Millions
Therapeutic Solutions International Inc   0.03 $ 0.098  Millions$ 3.575  Millions
Roivant Sciences Ltd   0.03 $ 124.795  Millions$ 4,684.338  Millions
Orgenesis Inc   0.03 $ 0.529  Millions$ 20.268  Millions
Aclarion Inc   0.02 $ 0.060  Millions$ 2.434  Millions
Vistagen Therapeutics Inc   0.02 $ 1.241  Millions$ 50.493  Millions
Verve Therapeutics Inc   0.02 $ 16.049  Millions$ 671.646  Millions
Therapeuticsmd Inc   0.02 $ 1.120  Millions$ 46.904  Millions
Abcellera Biologics Inc   0.02 $ 35.787  Millions$ 1,500.137  Millions
Omega Therapeutics Inc   0.02 $ 4.938  Millions$ 208.719  Millions
Aditxt Inc   0.02 $ 0.506  Millions$ 22.018  Millions
Uniqure N v   0.02 $ 19.003  Millions$ 854.015  Millions
Akili Inc   0.02 $ 1.948  Millions$ 88.088  Millions
Absci Corp  0.02 $ 5.347  Millions$ 245.673  Millions
Orchestra Biomed Holdings Inc   0.02 $ 2.216  Millions$ 105.020  Millions
Axim Biotechnologies Inc   0.02 $ 0.085  Millions$ 4.087  Millions
Marizyme Inc   0.02 $ 0.550  Millions$ 29.372  Millions
Bioxcel Therapeutics Inc   0.02 $ 1.756  Millions$ 99.143  Millions
Insight Molecular Diagnostics Inc   0.02 $ 1.382  Millions$ 78.748  Millions
Janux Therapeutics Inc   0.02 $ 7.287  Millions$ 449.435  Millions
Atrium Therapeutics Inc   0.02 $ 10.870  Millions$ 690.994  Millions
Praxis Precision Medicines Inc   0.02 $ 2.195  Millions$ 144.645  Millions
Envoy Medical Inc   0.01 $ 0.297  Millions$ 20.752  Millions
Catheter Precision Inc   0.01 $ 0.439  Millions$ 31.793  Millions
Shattuck Labs Inc   0.01 $ 2.058  Millions$ 152.435  Millions
Celldex Therapeutics inc   0.01 $ 6.072  Millions$ 478.510  Millions
Lyra Therapeutics Inc   0.01 $ 1.680  Millions$ 132.594  Millions
Abvc Biopharma Inc   0.01 $ 0.151  Millions$ 12.777  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.